No published randomized controlled trials exist for BPC-157 in orthopedic patients, and the FDA hasnt approved it
Qualitative assessment of nitric oxide production by fluorescent dye 3-Amino-4-aminomethyl-2,7-difluorescein, diacetate (DAF-FM DA, Sigma) HUVECs grown in M199 based culture medium was stimulated with 1.0 g/ml BPC 157 for 30 min to induce the nitric oxide generation
The products offered are not intended to diagnose, treat, cure, or prevent any disease
BPC-157 is a signaling peptidea short chain of amino acids that promotes tissue repair and reduces inflammation
That can mean fewer doses to reach the same effect
Thats why peptides and other forms of regenerative medicine can be effective for such a wide range of conditions